Infliximab Bests Second IVIG Infusion in Refractory Kawasaki Disease Infliximab Bests Second IVIG Infusion in Refractory Kawasaki Disease

In children with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease, infliximab was safe and more effective than a second IVIG infusion in resolving fever, decreasing hospital length of stay, and reducing the need for additional therapy, researchers say.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Pediatrics News Source Type: news